An Outcome Analysis of Primary Membranous Nephropathy

Active, not recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2029

Conditions

Membranous Nephropathy

Trial Locations (2)

"Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Daccò", Ranica

ASST HPG23 - Unità di Nefrologia, Bergamo

All Listed Sponsors

lead

Mario Negri Institute for Pharmacological Research

OTHER

NCT06242327 - An Outcome Analysis of Primary Membranous Nephropathy | Biotech Hunter | Biotech Hunter